Antazoline, Naphazoline

Optialerg 5 MG/ML + 0,25 MG/ML Colirio en Solucion

5,00 mg/ml + 0,25 mg/ml colirio en soluciónSpainMarketedAuthorised 14 Feb 2017

In other countries

The same active substances on other registers, the same brand first.

Apihist Eye\Nose DropSaudi Arabia · Amman Pharmaceutical Industries (API)Same form
Cooper A.R.Canada · 5 MG / ML + .5 MG / ML · Drops · Coopervision INC.Same substance
Vasocon A Eye DropsCanada · 5 MG / ML + .5 MG / ML · Drops · Novartis Ophthalmics Novartis Pharmaceuticals (Canada) INCSame substance
Vasocon A Oph SolnCanada · 5 MG / ML + .5 MG / ML · Drops · Iolab PharmaceuticalsSame substance
Nazolin Nasal DropsSaudi Arabia · Dar AldawaSame substance
NoscamSaudi Arabia · Riyadh PharmaSame substance
Antistin-Privin Eye DropsTaiwan · 點眼液劑 · 視康股份有限公司Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Antazoline, Naphazoline

Optialerg 5 MG/ML + 0,25 MG/ML Colirio en Solucion

5,00 mg/ml + 0,25 mg/ml colirio en soluciónSpainMarketedAuthorised 14 Feb 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vasocon-AUnited States · 0.5%; 0.05% · solution/drops · Novartis

Packs

Pack	Code	Status
OPTIALERG 5 MG/ML + 0,25 MG/ML COLIRIO EN SOLUCION, 1 frasco de 10 ml	714899

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Antazoline, Naphazoline
Strength: 5,00 mg/ml + 0,25 mg/ml
Dosage form: colirio en solución
Route: vía oftálmica
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 14 Feb 2017
Registration: 81752
Marketing authorisation holder: Laboratorios Cinfa S.A.
Procedure: National, MRP or DCP
Supply: Sin Receta